4
RUDN University Chemist is the most cited scientist according to Highly Cited Researchers

RUDN University Chemist is the most cited scientist according to Highly Cited Researchers

Director of the Scientific center "Molecular Design and Synthesis of Innovative Compounds for Medicine" of the Joint Institute of Chemical Research of the Russian Academy of Sciences Luc Alvarez de Sotomayor Rafael became one of the most cited scientists in the field of chemistry according to Highly Cited Researchers in 2021.

About chemistry, ecology, the role of RUDN in science and how to become the most cited researcher and how to maintain this status - in an interview.

What is your research aimed at?

Together with colleagues from the Scientific Center "Molecular Design and Synthesis of Innovative Compounds for Medicine" of the Joint Institute of Chemical Research (JINR) I work in several interdisciplinary areas: research in the field of nanochemistry, catalysis, "green" chemistry and modern organic chemistry under alternative conditions (microwave and flow synthesis).

What are you planning to study in the future?

We are focused on several new and interesting directions. This is the concept of waste recycling for further use in pharmaceuticals and the synthesis of active pharmaceutical ingredients (APIs) under flow synthesis conditions. The first results have already been published.

What problems of modern science are you interested in?

We are investigating the valorization of biomass — the reuse of waste to produce valuable products (from nanomaterials to fuels, chemicals and APIs). Of course, we are concerned about the global problem - the pollution of the planet with plastic waste. I hope that in the coming years we will be able to solve this.

You are the director of the scientific center "Molecular Design and Synthesis of innovative compounds for Medicine" of the OIHU RUDN. Tell us, what is the mission of the center?

The Center conducts research relevant to the pharmaceutical industry. The latest methods for the synthesis of active pharmaceutical ingredients (APIs) are being developed — this will help create drugs that will fight coronary heart diseases, Parkinson's and Alzheimer's diseases.

What role does the RUDN University play in your research?

RUDN has always supported our initiatives, provided infrastructure and provided logistical support. Thanks to this, the scientific center for "Molecular Design and Synthesis of Innovative compounds for Medicine" has been conducting its advanced research for several years. Undoubtedly, the success of the center was made possible in many ways thanks to the participation and support of the RUDN.

Do you have any rules — how to maintain the status of a highly cited scientist?

This is a very good question! Honestly, no. But, obviously, we need to strive to continue to be a source of inspiration for colleagues. It is almost a duty to conduct research while maintaining a leading position in the scientific field. However, you must definitely continue to enjoy science and strive to be a benchmark in your field.

What advice can you give to young scientists on how to get on the list of the most cited researchers in the world?

The main thing is to be creative and offer innovative approaches in research. This ensures that your scientific papers will be read and quoted. And, perhaps, they will become a milestone in their field.


For reference:

Clarivate Analytics is an international database of scientific citations. 1% of the best works in the Web of Science database are the works of highly cited scientists. The ratio of all world scientists to highly cited ones is 1000 to 1.

Scientific Center for "Molecular Design and Synthesis of Innovative Compounds for Medicine" of the Joint Institute of Chemical Research (JINR) RUDN specializes in organic synthesis and medical chemistry.

The work of the center is aimed at:

  • research activity in the field of synthesis of physiologically active azaheterocycles based on domino reactions of oxacarbenium ions;
  • development of innovative methods and technologies for obtaining and studying vinyls of iminium ions and donor-acceptor cyclopropanes.

Goals:

  • study and research of chemical compounds and search for ways of their rational and economical synthesis;
  • search and analysis of previously unknown intermediates and physiologically active compounds with potential applications in the pharmaceutical industry.

Tasks:

Solving problems of chemistry of heterocyclic compounds, nitroalkanes, ionic liquids, surfactants, as well as searching for new, previously unexplored and unexplored PD sensors.

Visiting Professors View all
12 Dec 2024
In 2024, RUDN started accepting applications for the new annual Prize for Scientific Achievement in Chemistry. The award was established to honour contributions to fundamental and applied research, as well as merit in achieving the UN Sustainable Development Goals.
482
Research and Innovative Activity View all
30 Dec 2020
In 2017, RUDN University scientists constructed a new explicit second-order precision difference scheme using modern computer algebra methods for 2-dimensional Navier-Stokes equations (NSE) [1]. This year, our mathematicians used a new scheme [2] to construct a numerical solution to the Cauchy problem with initial data (for t=0) as satisfying the continuity equation. Scientists managed to achieve previously unattainable accuracy of the continuity equation.
1661
Similar newsletter View all
08 Aug
RUDN University have won Two Gold medals at the XXVIII Moscow International Salon of Inventions and Innovative Technologies “Archimedes 2025”

Inventors from 26 countries and 35 regions of Russia presented more than 500 projects at the XVIII Moscow International Salon of Inventions and Innovative Technologies “Archimedes”. 340 projects belong to Russian participants, and their foreign colleagues — 215. RUDN University initiatives were awarded two gold medals.

129
08 Aug
Economic development of Greater Eurasia in a multipolar world discussion held in RUDN

RUDN hosted the XXVII International Scientific and Practical Conference “Actual Problems of Global Economy”. The conference was attended by more than 500 experts from 15 leading universities, including Brazil, China, Turkey and South Africa. The focus of the meeting was on cooperation between the countries of Greater Eurasia, interaction in the CIS and EAEU, as well as digitalization and deglobalization in the context of the multipolar world.

142
08 Aug
A study by RUDN University scientists took the silver medal at the Congress on pharmacotherapy

The III Russian Congress “Safety of pharmacotherapy 360°: Noli nocere!” was held in Moscow. The event is dedicated to topical issues of drug safety, pharmacovigilance and personalized medicine.

61
Similar newsletter View all